Investor

GEN Pharma

Last cheque observed Dec 2021. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

Series A

Cheques on record
0%of best year0cheques in 12 months, 1 on record
Since the last cheque1776days00hrs00min00sec
Median round$12MRounds led1 of 1
Pitch GEN Pharma

GEN Pharma highlights

  1. 01

    1 rounds on record

  2. 02

    Mostly Series A: 100% of its rounds

  3. 03

    Led 1 rounds

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first1 appearances

  1. 2021

    1 round

  2. Dec
    RS ResearchSeries A · TR · Firms' own news pages$12MLed

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Recently backed

The latest companies GEN Pharma put money into.

RS Research$12M · Dec 2021

Quick answers about GEN Pharma

What does GEN Pharma invest in?

GEN Pharma invests most often at Series A (100% of the rounds on record).

How active is GEN Pharma?

1 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in Dec 2021.

What has GEN Pharma invested in recently?

Its most recent investments on record: RS Research (Series A, Dec 2021).

How big are GEN Pharma's cheques?

The median round it joins is $12M.

Is GEN Pharma investing now?

No investments in the last 12 months; the latest was in Dec 2021.

What kind of investor is GEN Pharma?

GEN Pharma is a VC firm.

Where does this information on GEN Pharma come from?

From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it